Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.

Alice MariottiniChiara NozzoliIlaria CarliFilippo LandiValentina GigliAnna Maria RepiceAlessandra IpponiMichele CecchiRiccardo BoncompagniRiccardo SaccardiLuca Massacesi

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)

AHSCT may be highly cost-effective in selected aggressive RR-MS. Besides priceless benefits for treated individuals, cost-savings generated by AHSCT may contribute to improving healthcare assistance at a population level.

Keyphrases

multiple sclerosis
stem cell transplantation
healthcare
high dose
white matter
randomized controlled trial
systematic review
bone marrow
cell therapy
mass spectrometry
mesenchymal stem cells
systemic lupus erythematosus
health information
disease activity